# New York Regional Center for Diabetes Translation Research

> **NIH NIH P30** · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2022 · $198,546

## Abstract

Pilot & Feasibility Program
The Pilot and Feasibility Study (P&F) Program of the New York Regional Center for Diabetes Translation
Research (NY-CDTR) is designed to support primarily early stage investigators (ESIs), but also established
investigators in other fields to conduct research in diabetes, obesity and related cardiometabolic disorders.
Proposals that investigate health disparities related to diabetes and obesity, and these areas as they relate to
COVID-19, are encouraged. During our initial grant award cycle, we exceeded the mandated average of two
funded proposals per year for a P&F program, having a total of 13 P&F funded grants. For this renewal
application, we introduce a coordinated initiative to address racial disparities in obtaining NIH funded R01
grants. We solicit P&F proposals through our website and by email reaching out to our members and relevant
departments at our member institutions to solicit P&F proposals as well as through our Enrichment Program
and Cores. Overall, the goals of the P&F Program are to foster innovative areas of inquiry in diabetes or
obesity both by supporting and mentoring individual P&F recipients and to encourage collaboration among NY-
CDTR members. Our Specific Aims are: 1) To conduct annual P&F grant competitions. We have
increased our institutional collaboration and refined our procedures for our annual competition to increase the
number of responsive applications to a minimum of ten per year. We will expand the circulation of our annual
solicitation for P&F proposals through new collaborations with other NIH-supported Centers..2) To increase
P&F awardee and early stage investigator use of CDTR resources (Core services and Enrichment
programming). We are collaborating with the Core and Enrichment leaders to increase awareness and use of
NY-CDTR Core services and Program resources and to facilitate networking, which P&F awardees identified
as a priority on the Spring 2020 Membership Survey. 3) To objectively evaluate P&F awardee progress. We
are formalizing our evaluation metrics for all P&F projects to include a quarterly checklist-type status update
that reports on milestones achieved. 4) To increase P&F applications from URiM investigators and
evaluate relevant funding metrics. The P&F program will collaborate with the Enrichment Program and the
Administrative Core to engage the membership network, pipeline programs, and Diversity Supplement grant
recipients to solicit P&F proposals. We will assess barriers and facilitators for URiM early stage investigators in
obtaining R01 funding.

## Key facts

- **NIH application ID:** 10480958
- **Project number:** 5P30DK111022-08
- **Recipient organization:** ALBERT EINSTEIN COLLEGE OF MEDICINE
- **Principal Investigator:** JUDITH WYLIE-ROSETT
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $198,546
- **Award type:** 5
- **Project period:** 2016-09-20 → 2026-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10480958

## Citation

> US National Institutes of Health, RePORTER application 10480958, New York Regional Center for Diabetes Translation Research (5P30DK111022-08). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10480958. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*